Status:
UNKNOWN
Potential Pulmonary Benefit of Low Pressure Laparoscopic Cholecystectomy in Selected Patients
Lead Sponsor:
Peking Union Medical College Hospital
Conditions:
Cholecystitis/Cholelithiasis
Cholecystitis; Gallstone
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Standard Pressure Laparoscopic Cholecystectomy，as the standard for cholecystectomy, can lead to about 15% of pulmonary atelectasis. According to literature, low pressure laparoscopic cholecystectomy i...
Detailed Description
Standard Pressure Laparoscopic Cholecystectomy, SPLC；12-16mmHg，as the standard for cholecystectomy, can lead to about 15% of pulmonary atelectasis. According to literature, Low Pressure Laparoscopic ...
Eligibility Criteria
Inclusion
- Aged 18-85;
- Patients receiving laparoscopic cholecystectomy due to benign gallbladder diseases;
- Older patient or accompanied by cardiopulmonary diseases (age\>60 years, hypertension, Diabetes Mellitus, coronary heart disease, arrhythmia, chronic bronchitis, emphysema, history of heart surgery, history of lung surgery, history of mediastinal surgery, asthma, et al);
- Aged older than 60, with or without the above diseases;
- American society of Aneshesiologists (ASA) II or higher;
- Informed consent acquired.
Exclusion
- Having contraindication of laparoscopic operations;
- History at epigastric surgery. -
Key Trial Info
Start Date :
June 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
140 Patients enrolled
Trial Details
Trial ID
NCT04670952
Start Date
June 10 2019
End Date
December 1 2021
Last Update
December 23 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking Union Medical College Hospital
Beijing, Beijing Municipality, China, 100730